Cost-Effectiveness of the Screening and Treatment of Diabetic Retinopathy:What Are the Costs of Underutilization?
- 1 January 1992
- journal article
- general essays
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 8 (4) , 694-707
- https://doi.org/10.1017/s0266462300002385
Abstract
Diabetic retinal disease remains a leading cause of visual disability among those of working age. Controlled trials have demonstrated that timely diagnosis and photocoagulation treatment can reduce significantly the likelihood of visual impairment in affected diabetic patients. Using a prospective simulation model, we show that an annual screening and treatment program saves thousands of years of vision and reduces medical expenditures over the lifetime of a cohort of Swedish Type I diabetic patients.Keywords
This publication has 49 references indexed in Scilit:
- Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment.BMJ, 1989
- How Effective is the Referral Chain for Diabetic Retinopathy?Diabetic Medicine, 1989
- Guidelines for eye care in patients with diabetes mellitus. Results of a symposium. The Kentucky Diabetic Retinopathy GroupArchives of internal medicine (1960), 1989
- Course of Retinopathy in Children and Adolescents with Insulin-Dependent Diabetes mellitus: A Ten-Year StudyOphthalmologica, 1989
- The prevalence of retinopathy in the insulin-requiring diabetic patients of an english country townEye, 1988
- Natural history of diabetic retinopathy in insulin‐dependent juvenile diabeticsActa Ophthalmologica, 1987
- Blindness in insulin-treated diabetic patients with age at onset < 30 yearsJournal of Chronic Diseases, 1987
- Risk of Proliferative Diabetic Retinopathy in Juvenile-Onset Type I Diabetes: A 40-yr Follow-up StudyDiabetes Care, 1986
- Retinopathy in Young-onset Diabetic PatientsDiabetes Care, 1985
- The Evolution and Natural History of Diabetic RetinopathyInternational Ophthalmology Clinics, 1978